Yarrow Supercritical Extract Ameliorates the Metabolic Stress in a Model of Obesity Induced by High-Fat Diet
Open Access
Abstract
Nowadays, obesity and its associated metabolic disorders, including diabetes, metabolic syndrome, cardiovascular disease, or cancer, continue to be a health epidemic in westernized societies, and there is an increased necessity to explore anti-obesity therapies including pharmaceutical and nutraceutical compounds. Considerable attention has been placed on the identification of bioactive compounds from natural sources to manage the metabolic stress associated with obesity. In a previous work, we have demonstrated that a CO2 supercritical fluid extract from yarrow (Yarrow SFE), downregulates the expression of the lipogenic master regulator SREBF1 and its downstream molecular targets FASN and SCD in a tumoral context. Since obesity and diabetes are strongly considered high-risk factors for cancer development, herein, we aimed to investigate the potential therapeutic role of Yarrow SFE in the metabolic stress induced after a high-fat diet in mice. For this purpose, 32 C57BL/6 mice were distributed in four groups according to their diets: standard diet (SD); SD supplemented with Yarrow SFE (SD + Yarrow); high-fat diet (HFD); and HFD supplemented with Yarrow SFE (HFD + Yarrow). Fasting glycemia, insulin levels, homeostasis model assessment for insulin resistance (HOMA-IR), lipid profile, gene expression, and lipid content of liver and adipose tissues were analyzed after three months of treatment. Results indicate improved fasting glucose levels in plasma, enhanced insulin sensitivity, and diminished hypercholesterolemia in the HFD + Yarrow group compared to the HFD group. Mechanistically, Yarrow SFE protects liver from steatosis after the HFD challenge by augmenting the adipose tissue buffering capacity of the circulating plasma glucose.Keywords
Funding Information
- Spanish Ministry of Science , ((Plan Nacional I+D+i AGL2016-76736-C3))
- Regional Government of Community of Madrid ((P2013/ABI-2728, ALIBIRD-CM), (P2018/BAA-4343-ALIBIRD2020-CM))
- Fundación Ramón Areces (Investigación en Ciencias de la Vida y de la Materia)
This publication has 38 references indexed in Scilit:
- Role of Choline Deficiency in the Fatty Liver Phenotype of Mice Fed a Low Protein, Very Low Carbohydrate Ketogenic DietPLOS ONE, 2013
- Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progressionCurrent Opinion in Gastroenterology, 2012
- New insights into the mechanism of low high-density lipoprotein cholesterol in obesityLipids in Health and Disease, 2011
- Surrogate markers of insulin resistance: A reviewWorld Journal of Diabetes, 2010
- Liver lipid metabolismJournal of Animal Physiology and Animal Nutrition, 2008
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Protein Sensors for Membrane SterolsCell, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Obesity and insulin resistanceJournal of Clinical Investigation, 2000